Search results for "IMMUNOGLOBULINS"

showing 10 items of 112 documents

Production of an egg yolk antibody against Parietaria judaica 2 allergen

2009

Specific antibodies are essential tools for studying proteins as well as for diagnostic research in biomedicine. The egg yolk of immunized chicken is an inexpensive source of high-quality polyclonal antibodies. The 12-kDa Parietaria judaica 2 allergen was expressed as a fusion protein and was used to immunize Leghorn chickens. In this paper, we show, using 2-dimensional gel electrophoresis and immunoblotting, that chicken antibodies raised against a recombinant allergen can be used to recognize similar proteins from a pollen raw extract. Allergen identity was confirmed by nanoLC-nanospray-tandem mass spectrometry analysis. Our data demonstrate for the first time that a synergistic combinati…

food.ingredientImmunoglobulinsmedicine.disease_causeAntibodieslaw.inventionAllergenfoodlawYolkegg yolk antibodymedicineAnimalsGel electrophoresisDose-Response Relationship DrugbiologyGeneral MedicineAntigens Plantbiology.organism_classificationEgg YolkFusion proteinParietaria judaicaParietariaBiochemistryPolyclonal antibodiesImmunologyRecombinant DNAbiology.proteinParietaria judaicaPollenFemaleAnimal Science and ZoologyAntibodyChickensallergenPoultry Science
researchProduct

The role of maternal effects in host-parasite interactions: examination of the development of the immune defense in a colonial seabird, the black-leg…

2004

One of the main aims of evolutionary biology is to understand the mechanisms responsible for the phenotypic variation on which natural selection can act. Maternal effects occur when a mother's phenotype or her environment influence her offspring's phenotype. Despite the importance of such effects for the ecology of host-parasite interactions, their role has been relatively neglected to date. In this thesis, we examined how mothers influence the immune defense of their young in an environment that varies in space and time. This work has primarily focused on a colonial seabird, the black-legged kittiwake (Rissa tridactyla). Using this model, we have first shown that specific maternal antibodi…

immunité passive[SDE.MCG]Environmental Sciences/Global Changesdéfenses immunitairesinduced responseimmunoglobulins[ SDV.IMM.IA ] Life Sciences [q-bio]/Immunology/Adaptive immunologyIxodes uriae[ SDV.EE.SANT ] Life Sciences [q-bio]/Ecology environment/Healthticksindividual qualitymaladie de Lymetiques[ SDV.EE.IEO ] Life Sciences [q-bio]/Ecology environment/Symbiosis[SDV.BID.EVO] Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE][SDV.EE.SANT] Life Sciences [q-bio]/Ecology environment/HealthLyme diseaseimmunoglobulinesBorrelia burgdorferi s.l.[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/Health[ SDE.BE ] Environmental Sciences/Biodiversity and Ecology[SDV.BA.MVSA]Life Sciences [q-bio]/Animal biology/Veterinary medicine and animal Health[SDV.BID.EVO]Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE][SDV.BA.MVSA] Life Sciences [q-bio]/Animal biology/Veterinary medicine and animal Health[SDV.EE.IEO] Life Sciences [q-bio]/Ecology environment/Symbiosisimmune defense[SDE.BE] Environmental Sciences/Biodiversity and Ecologyinteractions hôte-parasiteeffets maternels[ SDE.MCG ] Environmental Sciences/Global Changes[SDE.MCG] Environmental Sciences/Global Changeshost-parasite interactions[ SDV.BID.EVO ] Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE]passive immunity[SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology[SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunologyqualité individuelle.maternal effectsoiseaux de mer[ SDV.BA.MVSA ] Life Sciences [q-bio]/Animal biology/Veterinary medicine and animal Healthectoparasitesréponse induite[SDE.BE]Environmental Sciences/Biodiversity and Ecologyseabirds[SDV.EE.IEO]Life Sciences [q-bio]/Ecology environment/Symbiosis
researchProduct

IVIG in APS pregnancy

2004

For more than two decades, the intravenous administration of high doses of IgG pooled from the plasma of healthy donors (immune globulin therapy, also known as ‘IVIG’) has benefited patients with a variety of autoimmune disorders. A potential therapeutic role of IVIG in the prevention of thrombosis and of miscarriages in antiphospholipid syndrome (APS) has been postulated. Multicenter randomized controlled trials attempted to define the role of IVIG in preventing pregnancy complications in APS indicate that simple anticoagulation could not be completely satisfactory, and certain patient subgroups might take advantage of IVIG therapy alone or in combination with heparin.

medicine.medical_specialtyAbortion Habitual030204 cardiovascular system & hematologyrecurrent fetal losslaw.invention03 medical and health sciences0302 clinical medicineRheumatologyRandomized controlled trialAntiphospholipid syndromelawPregnancyhemic and lymphatic diseasesInternal medicinemedicineHigh dosesHumans030203 arthritis & rheumatologyIVIGPregnancybiologybusiness.industryPregnancy Complications HematologicImmunoglobulins IntravenousThrombosisHeparinmedicine.diseaseAntiphospholipid SyndromeThrombosisPregnancy ComplicationsImmune Globulin TherapyImmunologybiology.proteinFemaleAntibodybusinessmedicine.drugAPS
researchProduct

Reply to Drs. Kiaei and Molinaro Regarding the Publication “Comparison of a Bridge Immunoassay with Two Bioassays for Thyrotropin Receptor Antibody D…

2020

Dear Editor,Drs. Kiaei and Molinaro 1 put forth two criticisms of the manuscript published by us 2. They state that the experimental design of this study is flawed and that the authors falsely claim that negative Thyretain™ TSI Reporter BioAssay results for two Graves’ diseases patients undergoing drug treatments means the absence of stimulating antibodies. To substantiate this claim Drs. Kiaei and Molinaro point out that the manufacturer of the Thyretain TSI Reporter BioAssay clearly states in the package insert that “[t]he effects of various drug therapies on the performance of this Kit have not been established” 1. Second, the package insert explicitly states that “[a] negative result do…

medicine.medical_specialtyLetter to the editorPackage insertEndocrinology Diabetes and MetabolismClinical BiochemistryThyrotropin receptor Antibody030209 endocrinology & metabolismBiochemistryAntibodies03 medical and health sciences0302 clinical medicineEndocrinologyClinical historyInternal medicineClinical informationHumansMedicineBioassayLetter to the EditorImmunoassaymedicine.diagnostic_testbusiness.industryBiochemistry (medical)Receptors ThyrotropinGeneral MedicineGraves DiseasePatient population030220 oncology & carcinogenesisImmunoassaybusinessImmunoglobulins Thyroid-StimulatingHormone and Metabolic Research
researchProduct

A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy

2006

Guillain-Barré Syndrome (GBS) is a demyelinating polyneuropathy of probable autoimmune pathogenesis characterized by rapidly progressive symmetric paralysis. In the literature some cases of GBS associated with anticancer chemotherapy are reported. We present a case of a 55-year old woman who complained of progressive motor deficit in four limbs, areflexia in lower limbs and facial nerve paralysis one week after beginning cisplatin-gemcitabine chemotherapy for metastatic lung cancer. The cerebrospinal fluid analysis showed a strong positive Pandy reaction with 435 mg/dl total protein. The electromyography and the electroneuronography established the diagnosis of inflammatory demyelinating po…

medicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentBone NeoplasmsGuillain-Barre SyndromeDeoxycytidineGastroenterologyPathogenesisCerebrospinal fluidCarcinoma Non-Small-Cell LungInternal medicineAntineoplastic Combined Chemotherapy ProtocolsElectroneuronographyParalysismedicineHumansPharmacology (medical)Lung cancerPharmacologyChemotherapyGuillain-Barre syndromebusiness.industryGuillain-Barré Syndrome neuropathy chemotherapy toxicity lung cancerImmunoglobulins IntravenousMiddle Agedmedicine.diseaseGemcitabineFacial nerveSurgeryInfectious DiseasesOncologyFemaleCisplatinmedicine.symptombusiness
researchProduct

Fresh cell therapy followed by fatal coma

1986

A 60-year-old woman received a 3-day course of nine injections of “fresh” cells from fetal lamb ovary, placenta, brain (hypothalamus) and liver. There were no immediate complications, but a few days later she developed headache, fever and hemiparesis. She subsequently fell into a coma and died 3 weeks after her fresh cell therapy and 2 weeks after the onset of her clinical symptoms. Autopsy revealed perivenous leucoencephalopathy with a probably steroid-treatment-induced paucity of perivascular inflammation. Fresh cell therapy, clinical symptomatology and morphological findings suggest, though do not prove, that this patient's monophasic and probably immune-mediated disease is a rare and fa…

medicine.medical_specialtyNeurologyCell- and Tissue-Based TherapyImmunoglobulinsOvaryAutopsyImmunoenzyme TechniquesCell therapyPonsPlacentamedicineHumansComaMyelin SheathCerebral CortexComabusiness.industryMacrophagesEncephalomyelitis Acute DisseminatedMiddle AgedSurgeryMicroscopy Electronmedicine.anatomical_structureHemiparesisNeurologyBlood-Brain BarrierAnesthesiaFemaleNeurology (clinical)medicine.symptomComplicationbusinessJournal of Neurology
researchProduct

Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial

2021

Abstract Background The role of intravenous immunoglobulins (IVIG) during sepsis is controversial, as different trials on IVIG have observed inconsistent survival benefits. We aimed to elucidate the possible association and clinical significance between circulating levels of immunoglobulins. Methods In a subset of 956 patients with severe sepsis and septic shock of the multicentre, open-label RCT ALBIOS, venous blood samples were serially collected 1, 2, and 7 days after enrolment (or at ICU discharge, whichever came first). IgA, IgG and IgM concentrations were assayed in all patients on day 1 and in a subgroup of 150 patients on days 2 and 7. Ig concentrations were measured employing a tur…

medicine.medical_specialtySepsiIgGSecondary infectionCritical Care and Intensive Care MedicineGastroenterologylaw.inventionSepsisRandomized controlled triallawInternal medicineSepsisSeptic shockRisk of mortalitymedicineClinical significanceMortalitybusiness.industrySeptic shockRC86-88.9ResearchMedical emergencies. Critical care. Intensive care. First aidVenous bloodmedicine.diseaseIgM ImmunoglobulinsbusinessIgA; IgG; IgM Immunoglobulins; Mortality; Sepsis; Septic shockIgM ImmunoglobulinIgACohort study
researchProduct

Comparative effects of UVA and UVB irradiation on the immune system of fish.

2000

Aquatic organisms can be harmed by the current levels of solar ultraviolet radiation. We have recently shown that exposure of fish to UVB irradiation alters the functioning of the fish immune system, but the effects of UVA radiation are unknown. The present study continues this work by characterizing UVA irradiation-induced immunological changes in fish. Roach, a cyprinid fish, were exposed to a single dose of either UVA (3.6 J/cm2) or UVB (0.5 J/cm2) irradiation. Both irradiations suppressed transiently mitogen-stimulated proliferation of blood lymphocytes. UVA, but not UVB, decreased hematocrit, plasma protein, and plasma immunoglobulin levels and increased the proportions of blood cells …

medicine.medical_specialtyUltraviolet RaysBiophysicsCyprinidaeImmunoglobulinsHematocritLymphocyte ActivationLeukocyte CountImmune systemInternal medicinemedicineAnimalsRadiology Nuclear Medicine and imagingLymphocytesRadiationHematologyintegumentary systemRadiological and Ultrasound Technologybiologymedicine.diagnostic_testGranulocytosisBlood Proteinsmedicine.diseaseMolecular biologyBlood proteinsBlood chemistryHematocritImmunologybiology.proteinErythrocyte Countsense organsAntibodyLymphocytopeniaJournal of photochemistry and photobiology. B, Biology
researchProduct

Brainstem Auditory Evoked Potentials and Visual Potentials in Kawasaki Disease: An Observational Monocentric Study

2020

Background: Kawasaki Disease is a systemic vasculitis, particularly involving coronary arteries. Rare involvement of other vascular districts is described, as central nervous system arteries, leading to a vasculitic neuropathy. Sensorineural hearing loss and alterations of evoked potentials are uncommonly reported complications.Methods: In an observational monocentric study, 59 children (37 males; 22 females; mean age: 2.7 ± 2.2 years) with documented Kawasaki Disease were enrolled. No risk factors for hearing loss and/or neurological impairment were identified in the cohort. Brainstem auditory evoked potentials and visual evoked potentials were correlated with clinical, hamatological and r…

medicine.medical_specialtygenetic structuresHearing lossvisual evoked potentialsCentral nervous systemintravenous immunoglobulinscoronary artery lesionPediatrics03 medical and health sciences0302 clinical medicine030225 pediatricsInternal medicineintravenous immunoglobulinmedicinekawasaki diseasePathologicalOriginal Researchbusiness.industrylcsh:RJ1-570lcsh:Pediatricscoronary artery lesionsmedicine.diseaseCoronary arteriesmedicine.anatomical_structurePediatrics Perinatology and Child Healthbrainstem auditory evoked potentialCardiologyKawasaki diseaseSensorineural hearing lossBrainstemmedicine.symptomvisual evoked potentialbusinessbrainstem auditory evoked potentials030217 neurology & neurosurgeryArteryFrontiers in Pediatrics
researchProduct

Are biological drugs effective and safe in older severe asthmatics?

2019

Introduction: The treatment of asthma in older ages follows the recommendations of international guidelines for the management of asthma in younger ages, although older age has always represented an exclusion criterion for eligibility to pharmacological trials. This poses a clinical challenge when deciding whether elderly severe asthmatics are candidates for biological drugs. Areas covered: The current article has a narrative structure to review the current literature on efficacy and safety of novel pharmacological drugs against immunoglobulins and interleukins that mediate and orchestrate the main inflammatory pathways in severe asthma, in order to explore whether older subjects (i.e. >…

medicine.medical_specialtypulmonary eosinophilia/drug therapyeducationImmunoglobulinsmonoclonal030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato RespiratorioAnti-asthmatic AgentSeverity of Illness IndexBiological drugs03 medical and health sciences0302 clinical medicineimmune system diseasesInternal medicineSeverity of illnessImmunoglobulinHumansMedicineAnti-Asthmatic AgentPharmacology (medical)Age FactorAnti-Asthmatic AgentsAsthmaAgedRandomized Controlled Trials as TopicBiological ProductsAsthma/drug therapybiologyhumanizedbusiness.industryInterleukinsAge FactorsGeneral MedicineInterleukinmedicine.diseaseAsthmarespiratory tract diseasesantibodie030220 oncology & carcinogenesisMonoclonalPractice Guidelines as Topicbiology.proteinBiological Productanti-asthmatic agents/pharmacologyAntibodybusinessHuman
researchProduct